You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BARINTHUS BIOTHERAPEUTICS PLC. - ADR

Barinthus Biotherapeutics Plc. - ADR XNAS: BRNS

Barinthus Biotherapeutics Plc. - ADR Live Share Price Today, Share Analysis and Chart

Download real time

0.99 -0.02 (-1.98%)

76.20% Fall from 52W High

10,765 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Barinthus Biotherapeutics Plc. - ADR is on 27 Mar 2025 for the purpose of Barinthus Biotherapeutics PLC Annual Report for 2024 See details

6

S

12

W

1

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

Not enough data available


Barinthus Biotherapeutics ... Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2602550Actual RevenueAvg. Estimate
Hit

Barinthus Biotherapeutics Plc. - ADR's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

Current EPS
-1.5
Avg. Estimate
-1.5
Low Estimate
-1.5
High Estimate
-1.5
Current EPS
Avg. Estimate

Consensus Recommendation

3 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Buy2Strong Buy

The consensus recommendation from 3 analysts for Barinthus Biotherapeutics Plc. - ADR is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Barinthus Biotherapeutics ... Stock Analysis

Barinthus Biotherapeutics ... stock analysis with key metrics, changes, and trends.

Barinthus Biotherapeutics ... MetricVALUECHANGE %TRENDANALYSIS
Stock Price$0.99-61.63%negative

Stock Price fell 61.63% and underperformed its sector by 70.7% in the past year.

Mutual Fund Holding3.00 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 3%.

Institutional Holding35.90 %-1.44%negative

Institutional Holding decreased by 1.44% in the last quarter to 35.9.



Loading data..

Barinthus Biotherapeutics Plc. - ADR - Company Profile

Barinthus Biotherapeutics Plc. - ADR Management structure

All Gross Remunerations are in USD
Mr. Graham Griffiths
Chief Operating Officer
-
2025
Gross Remuneration
Year
Ms. Gemma Brown
Chief Financial Officer and Principal Accounting Officer
-
2025
Gross Remuneration
Year

Barinthus Biotherapeutics Plc. - ADR Board of directors

All Gross Remunerations are in USD
Mr. Robin Wright
Chairman of the Board
145.67 K
2022
Gross Remuneration
Year
Dr. Pierre A. Morgon, Pharm.D.
Independent Director
115.72 K
2022
Gross Remuneration
Year
Ms. Karen A. Dawes, M.A.,M.B.A.
Independent Director
112.01 K
2022
Gross Remuneration
Year
Dr. Anne M. Phillips, M.D.
Independent Director
111.47 K
2022
Gross Remuneration
Year
Dr. Joseph C.F. Scheeren
Independent Director
110.16 K
2022
Gross Remuneration
Year
Mr. Alex Hammacher
Director
103.1 K
2022
Gross Remuneration
Year

Barinthus Biotherapeutics Plc. - ADR FAQ

How is Barinthus Biotherapeutics Plc. - ADR today?
Barinthus Biotherapeutics Plc. - ADR today is trading in the red, and is down by -1.98% at 0.99.
Barinthus Biotherapeutics Plc. - ADR is currently trading down -1.98% on an intraday basis. In the past week the stock fell -6.60%. stock has been down -14.66% in the past quarter and fell -61.63% in the past year. You can view this in the overview section.